Skip to Content
Leave of Absence through June 2013Professor of Surgery
- Vascular Surgery
Primary Office: 1532 JCPIowa City, IA 52242
Primary Office Phone: 319-356-3305
MD, American University of Beirut
Fellowship, Trauma, New York University Medical CenterFellowship, General Surgery, New York University Medical CenterFellowship, Vascular Surgery , University of IowaResidency, General Surgery, New York University Medical Center
Surgical Critical Care, General Vascular Surgery , American Board of Surgery
Dr. Hoballah's research focuses on clinical problems in vascular surgery. One challenging topic is the management of ruptured abdominal aortic aneurysms and the associated problems related to abdominal compartmental hypertension. Currently the experience at the University of Iowa with ruptured abdominal aortic aneurysm is being reviewed with special attention to the management of abdominal compartmental hypertension and its effect on renal perfusion and management by open abdomen. Another clinical issue that is being evaluated is the value of screening and surveillance of the abdominal aorta and the carotid arteries in patients presenting with lower extremity occlusive disease or in patients undergoing coronary artery bypass surgery. Another research interest is the management of acute limb ischemia. This continues to be a very challenging problem with respect to revascularization using surgical techniques versus endovascular techniques with lytic therapy. This is especially true due to the changes in available lytic therapy drugs. The experience with the use of lytic therapy in the management of acute arterial occlusion is currently being investigated to determine the group of patients that would benefit most form such an approach versus who would benefit more from surgical reconstruction. One additional topic is the management of chronic arterial insufficiency as manifested by intermittent claudication. The current therapy is limited to an exercise program and one drug therapy. A new industry trial is focusing on the use of a new drug in the management of intermittent arterial claudication. The endovascular treatment of infrainguinal occlusive disease remains a controversial and challenging topic. The newer devices have become more available, including a new atherectomy device. The treatment of patients with infrainguinal occlusive disease using the new modality of atherectomy has been used in an isolated group of patients. The outcome of atherectomy is being re- evaluated in the long term and compared to other endovascular methods of therapy.
Date Last Modified: 01/08/2013 -
Copyright © 2011 The University of Iowa. All Rights Reserved.